Thomas A MCCOURT Insider Trading $XLRN ACCELERON PHARMA INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas A MCCOURT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas A MCCOURT. Thomas A MCCOURT is Director in ACCELERON PHARMA INC ($XLRN) and Chief Commercial Officer in IRONWOOD PHARMACEUTICALS INC ($IRWD) and President in IRONWOOD PHARMACEUTICALS INC ($IRWD).
Thomas A MCCOURT in ACCELERON PHARMA INC
Trading Symbol: XLRNIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Thomas A MCCOURT: Director
Holdings: 13,544 shares
Current Value: $321,535
Latest Transaction: Apr 21 2021
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Thomas A MCCOURT in ACCELERON PHARMA INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | M | 40.61 | 7,500 | 304,575 | 0 | |
Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 121.23 | 200 | 24,246 | 6,044 | 6.2 K to 6 K (-3.20 %) |
Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 120.16 | 1,143 | 137,343 | 6,244 | 7.4 K to 6.2 K (-15.47 %) |
Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 119.36 | 4,030 | 481,021 | 7,387 | 11.4 K to 7.4 K (-35.30 %) |
Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 118.39 | 2,127 | 251,816 | 11,417 | 13.5 K to 11.4 K (-15.70 %) |
Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Buy | M | 40.61 | 7,500 | 304,575 | 13,544 | 6 K to 13.5 K (+124.09 %) |
Feb 02 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | A | 115.53 | 3,222 | 372,238 | 3,222 | |
Feb 02 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Grant | A | 0.00 | 1,622 | 0 | 6,044 | 4.4 K to 6 K (+36.68 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | M | 30.17 | 3,272 | 98,716 | 0 | |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | M | 32.98 | 20,000 | 659,600 | 0 | |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 91.38 | 200 | 18,276 | 4,422 | 4.6 K to 4.4 K (-4.33 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 90.64 | 13,896 | 1,259,533 | 4,622 | 18.5 K to 4.6 K (-75.04 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 89.98 | 9,176 | 825,656 | 18,518 | 27.7 K to 18.5 K (-33.13 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Buy | M | 30.17 | 3,272 | 98,716 | 27,694 | 24.4 K to 27.7 K (+13.40 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Buy | M | 32.98 | 20,000 | 659,600 | 24,422 | 4.4 K to 24.4 K (+452.28 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | M | 30.17 | 3,272 | 98,716 | 0 | |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | M | 32.98 | 20,000 | 659,600 | 0 | |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 91.38 | 200 | 18,276 | 4,422 | 4.6 K to 4.4 K (-4.33 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 90.64 | 13,896 | 1,259,533 | 4,622 | 18.5 K to 4.6 K (-75.04 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 89.98 | 9,176 | 825,656 | 18,518 | 27.7 K to 18.5 K (-33.13 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Buy | M | 30.17 | 3,272 | 98,716 | 27,694 | 24.4 K to 27.7 K (+13.40 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Buy | M | 32.98 | 20,000 | 659,600 | 24,422 | 4.4 K to 24.4 K (+452.28 %) |
Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | A | 52.99 | 8,185 | 433,723 | 8,185 | |
Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Grant | A | 0.00 | 1,377 | 0 | 4,422 | 3 K to 4.4 K (+45.22 %) |
Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | A | 41.64 | 7,500 | 312,300 | 7,500 | |
Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Grant | A | 0.00 | 1,250 | 0 | 3,045 | 1.8 K to 3 K (+69.64 %) |
Mar 05 2018 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | A | 40.61 | 7,500 | 304,575 | 7,500 | |
Mar 05 2018 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Grant | A | 0.00 | 1,250 | 0 | 1,795 | 545 to 1.8 K (+229.36 %) |
Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | A | 30.17 | 3,272 | 98,716 | 3,272 | |
Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Grant | A | 0.00 | 545 | 0 | 545 | 0 to 545 |
Jul 25 2016 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | A | 32.98 | 20,000 | 659,600 | 20,000 |
Page: 1